Invivyd Inc (IVVD) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 3[1], 1 Phase 1[2].
Trial NCT07298434[4] evaluates VYD2311-SD in COVID-19 with a target enrollment of 1770 participants.
No Form 4 insider filings for IVVD were recorded at the SEC in the past 30 days[5].